Key Market Indicator:
F&G: 52
25.077,41 NASDAQ · 48.619,99 DOW · 6.825,55 S&P · 4.865,99 Gold · 63,65 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
Hedge the Peak | Protect your Profits
© Globe Newswire
02.12.2024
ISIN: SE0002190926
Karolinska Development AB
KDEV
LISTED
STO
Karolinska Development implements organizational changes for more efficient portfolio management
Article
News Preview
STOCKHOLM, SWEDEN – December 2, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that the company has decided to implement organizational changes in order to reduce the cost base of its operations. The changes involve reducing the management team by one person and giving notice of redundancy to a total of three employees. Th...
Themefolio
Profiler
Peergroup
© EQS Newswire
02.12.2024
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer builds new production capacities for glass syringes at Skopje site 
Article
News Preview
Gerresheimer builds new production capacities for glass syringes at Skopje site  Expansion of the site in the Republic of North Macedonia with a new production hall for glass syringes Total investment volume of over EUR 100 million Around 250 new jobs for skilled workers from the region Ramp-up of syringe production starting by the end of 2024 ......
Themefolio
Profiler
Peergroup
© EQS Newswire
02.12.2024
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer baut am Standort Skopje neue Produktionskapazitäten für Glasspritzen auf
Article
News Preview
Gerresheimer baut am Standort Skopje neue Produktionskapazitäten für Glasspritzen auf  Erweiterung des Standortes in der Republik Nordmazedonien um neue Produktionshalle für Glasspritzen Gesamtinvestitionsvolumen von über 100 Mio. Euro  Rund 250 neue Arbeitsplätze für Fachkräfte aus der Region Anlauf der Spritzenproduktion ab Ende 2024  Düsseld......
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
More Info
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
02.12.2024
ISIN: US98887Q1040
Zai Lab Limited
ZLAB
LISTED
NASDAQ
Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer
Article
News Preview
Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) and Novocure (NASDAQ: NVCR) announced today that the pivotal, Phase 3 PANOVA-3 trial met its primary endpoint, demonstrating a statistically significant improvement in median overall survival (mOS) versus control. PANOVA-3 evaluated the use of Tumor Treating Fields (TTFields) therapy concomitantly with ge...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
02.12.2024
ISIN: CA60255C8850
Definium Therapeutics, Inc.
DFTX
LISTED
NASDAQ
MindMed Announces New Employee Inducement Grants
Article
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to four newly hired non-executive employees consisting of options to purchase an aggregate of 171,000 common shar...
Themefolio
Profiler
Peergroup
© EQS Newswire
02.12.2024
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Eckert & Ziegler Begins Production of Actinium-225, Paving the Way for GMP-Grade Supply
Article
News Preview
Berlin, 02 December 2024. Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler) today celebrates the successful start of Actinium-225 (Ac-225) production, addressing the global shortage of this critical radionuclide. This milestone marks a major success of the common project with the Nuclear Physics Institute of the Czech Academy of Sciences......
Themefolio
Profiler
Peergroup
© EQS Newswire
02.12.2024
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Eckert & Ziegler startet Produktion von Actinium-225 und ebnet den Weg für die Versorgung mit GMP-Material
Article
News Preview
Berlin, 02. Dezember 2024. Die Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler) feiert heute den erfolgreichen Start der Produktion von Actinium-225 (Ac-225) und begegnet damit dem weltweiten Mangel an diesem wichtigen Radionuklid. Dieser Meilenstein ist ein enormer Erfolg für das gemeinsame Projekt mit dem Institut für Kernphysik der A......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
01.12.2024
ISIN: BE0003755692
AGFA Gevaert NV
AGFB
LISTED
EURONEXT
At RSNA 2024, AGFA HealthCare Presents RUBEE(R) AI Powered by CARPL Platform
Article
News Preview
Bringing yet another clinical breakthrough to the 2024 RSNA Annual Meeting, AGFA HealthCare is excited to announce a new partnership with CARPL.ai - the world's largest radiology AI marketplace. MORTSEL, BE / ACCESSWIRE / December 1, 2024 / In Chicago, AGFA HealthCare is set to demonstrate the seamless integration of CARPL.ai into AGFA HealthCare E...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.11.2024
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Article
News Preview
COPENHAGEN, Denmark, November 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.11.2024
ISIN: DK0060336014
Novozymes A/S
NSIS B
LISTED
CPH
Major shareholder announcement
Article
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
© PR Newswire
29.11.2024
ISIN: SE0000135485
RaySearch Laboratories AB (publ)
RAY B
LISTED
STO
RaySearch Laboratories to present ongoing development in liver ablation therapy* at RSNA 2024
Article
News Preview
STOCKHOLM, Nov. 29, 2024 /PRNewswire/ -- RaySearch will be exhibiting its advanced software solutions at RSNA in Chicago, Illinois, December 1 – 4. RSNA is the largest conference show in the field of radiology which opens new horizons for the company. Participants can book demonstrations of the module, which is ongoing development, for liver abla...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.11.2024
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Article
News Preview
COPENHAGEN, Denmark, November 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 218,750 as a consequence of employees’ exercise of warrants....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
29.11.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec announces change in Management Board
Article
News Preview
Dr Craig Johnstone steps down as Chief Operating Officer effective 31 December 2024 Distribution of responsibilities internally Hamburg, Germany, 29 November 2024: Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that its Chief Operating Officer, Dr Craig Johnstone, will step down and leave th......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.11.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec gibt Veränderung im Vorstand bekannt
Article
News Preview
Dr. Craig Johnstone tritt mit Wirkung zum 31. Dezember 2024 als Chief Operating Officer zurück Verantwortlichkeiten werden intern verteilt Hamburg, 29 November 2024: Die Evotec SE (Frankfurter Wertpapierbörse: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) gab heute bekannt, dass ihr Chief Operating Officer, Dr. Craig Johnstone, Evotec mit Wir......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.11.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec Announces Change in Management Board
Article
News Preview
Dr Craig Johnstone steps down as Chief OperatingOfficer effective 31 December 2024Distribution of responsibilities internally HAMBURG, GERMANY / ACCESSWIRE / November 29, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that its Chief Operating Officer, Dr Craig Johnstone, will step down...
Themefolio
Profiler
Peergroup
© PR Newswire
28.11.2024
ISIN: SE0006091997
Immunovia AB (publ)
IMMNOV
LISTED
STO
Immunovia to present at the Redeye Technology & Life Science Day
Article
News Preview
LUND, Sweden, Nov. 28, 2024 /PRNewswire/ -- Immunovia (STO: IMMNOV), the pancreatic cancer diagnostics company, will present at the Redeye Technology & Life Science Day on December 3, hosted by Redeye. Redeye Technology & Life Science Day gathers over 40 leading Nordic companies for a live-streamed event to showcase the groundbreaking wo...
Themefolio
Profiler
Peergroup
© PR Newswire
28.11.2024
ISIN: SE0009807266
Integrum AB (B)
INTEG B
LISTED
STO
Integrum Launches Service Initiative to Strengthen U.S. Market Growth
Article
News Preview
MÖLNDAL, Sweden, Nov. 28, 2024 /PRNewswire/ -- Integrum AB (publ), ticker (STO: INTEG), a leader in medical technology and developer of the bone-anchored OPRA® Implant System, announces the launch of a new service initiative to enhance warranty and service support for its Axor™ II devices. This initiative is a critical step in advancing Integrum'...
Themefolio
Profiler
Peergroup
© PR Newswire
28.11.2024
ISIN: SE0022419784
Sectra AB
SECT_B
LISTED
STO
Invitation to presentation of Sectra's six-month interim report 2024/2025 and date for CMD
Article
News Preview
LINKÖPING, Sweden, Nov. 28, 2024 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) invites investors, analysts, and the media to a presentation of the company's six-month report with President Torbjörn Kronander and CFO Jessica Holmquist. Sectra will also hold a Capital Markets Day (CMD) on March 27,...
Themefolio
Profiler
Peergroup
© PR Newswire
28.11.2024
ISIN: SE0022419784
Sectra AB
SECT_B
LISTED
STO
Belgian hospital chooses Sectra's enterprise imaging solution to support faster radiology diagnostics for better patient care
Article
News Preview
LINKÖPING, Sweden, Nov. 28, 2024 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide AZ Sint-Lucas Gent in Belgium with its enterprise imaging solution. The solution will allow radiologists to complete the entire diagnostic process within a single application, with all necessary tools easil...
Themefolio
Profiler
Peergroup
© EQS Newswire
28.11.2024
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon berichtet Neunmonatsergebnis 2024 und setzt Wachstumskurs mit weiteren operativen Erfolgen fort
Article
News Preview
Pressemitteilung // 28. November 2024   Formycon berichtet Neunmonatsergebnis 2024 und setzt Wachstumskurs mit weiteren operativen Erfolgen fort Hervorragendes drittes Quartal mit Produktzulassungen für FYB202 in den Schlüsselmärkten USA und Europa Keytruda®-Biosimilar-Kandidat FYB206 startet klinisches Entwicklungsprogramm (Phase I und Phase I......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.11.2024
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon reports nine-month results for 2024 and continues growth trajectory with further operational successes
Article
News Preview
Press Release // November 28, 2024   Formycon reports nine-month results for 2024 and continues growth trajectory with further operational success Excellent third quarter with product approvals for FYB202 in the key markets USA and Europe Keytruda® biosimilar candidate FYB206 starts clinical development program (phase I and phase III study) Dev......
Themefolio
Profiler
Peergroup
© BusinessWire
28.11.2024
ISIN: US98887Q1040
Zai Lab Limited
ZLAB
LISTED
NASDAQ
Zai Lab Announces the Inclusion of AUGTYRO® (repotrectinib) for ROS1+ NSCLC and Other Updates in China’s National Reimbursement Drug List
Article
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the 2024 National Reimbursement Drug List (NRDL) released by China’s National Healthcare Security Administration (NHSA) has been updated to include the following medicines and indications: AUGTYRO® (repotrectinib) is included in the NRDL for the treatment of adult patients with loc...
Themefolio
Profiler
Peergroup
© PR Newswire
28.11.2024
ISIN: SE0010323311
BioArctic AB
BIOA B
LISTED
STO
Leqembi® launched in South Korea
Article
News Preview
STOCKHOLM, Nov. 28, 2024 /PRNewswire/ - BioArctic AB's (publ) (NASDAQ STOCKHOLM: BIOA B) partner Eisai today announced today that Leqembi® (generic name: lecanemab) has been launched in South Korea. Leqembi received approval in South Korea in May 2024 for treatment in adult patients with mild cognitive impairment due to Alzheimer's disease (AD) o...
Themefolio
Profiler
Peergroup
© PR Newswire
28.11.2024
ISIN: SE0010323311
BioArctic AB
BIOA B
LISTED
STO
Leqembi® launched in South Korea
Article
News Preview
STOCKHOLM, Nov. 27, 2024 /PRNewswire/ - BioArctic AB's (publ) (NASDAQ STOCKHOLM: BIOA B) partner Eisai today announced today that Leqembi® (generic name: lecanemab) has been launched in South Korea. Leqembi received approval in South Korea in May 2024 for treatment in adult patients with mild cognitive impairment due to Alzheimer's disease (AD) o...
Themefolio
Profiler
Peergroup
© BusinessWire
27.11.2024
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
Article
News Preview
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) investors concerning the Company’s possible violations of the federal securities laws. If you suffered a loss on your Icon investments or would like...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.11.2024
ISIN: NL0012169213
Qiagen NV
QGEN
LISTED
NYSE
QIAGEN führt neuartige Tools zur Anpassung von digitalen PCR‑Assays und NGS-Panels für die mikrobielle Analyse ein
Article
News Preview
QIAGEN führt das erste Design-Tool für individuell anpassbare digitale PCR-Assays im Markt ein, ausgestattet mit fortschrittlichen Design-Algorithmen für verschiedene mikrobielle Anwendungen und kundenspezifische NGS-Panels // Erstes Custom Assay Design Tool für mikrobielle dPCR-Assays bietet hohe Flexibilität in der digitalen PCR-Analyse von bakte...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.11.2024
ISIN: DK0060336014
Novozymes A/S
NSIS B
LISTED
CPH
Major shareholder announcement
Article
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
© PR Newswire
27.11.2024
ISIN: SE0006091997
Immunovia AB (publ)
IMMNOV
LISTED
STO
Immunovia Publishes Interim Report for January-September 2024
Article
News Preview
LUND, Sweden, Nov. 27, 2024 /PRNewswire/ --  July-September 2024 Net sales, which for the quarter only included royalties, amounted to 235 KSEK (488).Net earnings amounted to -51.1 MSEK (-38.6).Earnings per share before and after dilution were -0.73 SEK (-0.91).Cash flow from operating activities amounted to -21.2 MSEK (-35.6).Cash and cash equi...
Themefolio
Profiler
Peergroup
© EQS Newswire
27.11.2024
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Eckert & Ziegler Achieves European Approval for Theralugand® - Lutetium-177 Chloride (n.c.a)
Article
News Preview
Berlin, 27 November 2024. Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler) today received approval of its proprietary non-carrier added Lutetium-177 chloride, Theralugand®, by the European Commission (EC). This enables the use of the radiopharmaceutical medicinal product Theralugand® in routine clinical applications throughout the Europ......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.11.2024
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Eckert & Ziegler erhält europäische Zulassung für Theralugand® - Lutetium-177 Chlorid (n.c.a)
Article
News Preview
Berlin, 27. November 2024. Die Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler) hat die Zulassung für ihr trägerfreies Lutetium-177-Chlorid, Theralugand®, durch die Europäische Kommission (EK) erhalten. Damit kann das Radiopharmazeutikum Theralugand® nun routinemäßig für klinische Anwendungen im gesamten Europäischen Wirtschaftsraum (EW......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
27.11.2024
ISIN: BE0003755692
AGFA Gevaert NV
AGFB
LISTED
EURONEXT
Self Regional Healthcare Brings Future-Ready Enterprise Imaging Cloud Technology Into South Carolina With AGFA Healthcare
Article
News Preview
Self Regional Healthcare aims to upgrade its PACS, enhance diagnostic imaging capabilities, and strengthen its financial position while optimizing staff workflows. By adopting AGFA HealthCare's Enterprise Imaging Cloud, they are poised to successfully achieve these objectives. MORTSEL, BE / ACCESSWIRE / November 27, 2024 / In a significant leap for...
Themefolio
Profiler
Peergroup
© PR Newswire
27.11.2024
ISIN: SE0006091997
Immunovia AB (publ)
IMMNOV
LISTED
STO
Immunovia Publishes Interim Report for January-September 2024
Article
News Preview
LUND, Sweden, Nov. 27, 2024 /PRNewswire/ --  July-September 2024 Net sales, which for the quarter only included royalties, amounted to 235 KSEK (488).Net earnings amounted to -51.1 MSEK (-38.6).Earnings per share before and after dilution were -0.73 SEK (-0.91).Cash flow from operating activities amounted to -21.2 MSEK (-35.6).Cash and cash equi...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.11.2024
ISIN: FI0009014377
Orion Oyj
ORNBV
LISTED
HEL
142,701 Orion Corporation A shares converted into B shares
Article
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE27 NOVEMBER 2024 at 9.00 EET          ...
Themefolio
Profiler
Peergroup
© BusinessWire
26.11.2024
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
Article
News Preview
Law Offices of Howard G. Smith continues its investigation on behalf of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) investors concerning the Company’s possible violations of federal securities laws. On October 23, 2024, Icon released its third quarter 2024 financial results, missing consensus estimates “due to specific c...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2024
ISIN: BE0003874915
Fagron NV
FAGR
LISTED
EURONEXT
Disclosure of notification received from FMR LLC
Article
News Preview
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 26 November 2024 – 6.45 PM CET...
Themefolio
Profiler
Peergroup
© BusinessWire
25.11.2024
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
The Law Offices of Frank R. Cruz Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
Article
News Preview
The Law Offices of Frank R. Cruz continues its investigation of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) on behalf of investors concerning the Company’s possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On October 23, 2024, Icon released its thir...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.11.2024
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab to Present at Citi’s Global Healthcare Conference
Article
News Preview
Media ReleaseCOPENHAGEN, Denmark; November 25, 2024...
Themefolio
Profiler
Peergroup
© BusinessWire
25.11.2024
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Tempus to Participate in the Piper Sandler 36th Annual Healthcare Conference
Article
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024, held in New York, New York. Tempus Founder and CEO, Eric Lefkofsky, will participate in a fireside discussion at the c...
Themefolio
Profiler
Peergroup
© BusinessWire
25.11.2024
ISIN: FR0014000MR3
Eurofins Scientific SE
ERF
LISTED
EURONEXT
Eurofins Sustainability Services Introduces CleanAir Check Service for Volatile Organic Compounds (VOCS) Testing
Article
News Preview
Eurofins Sustainability Services, a full-service provider for retailers, brands, and manufacturers of consumer products, has grown its extensive service offering to include a CleanAir Check service that tests for Volatile Organic Compounds (VOCs). Given that VOCs pose significant concerns for human health and the environment, increasingly stringen...
Themefolio
Profiler
Peergroup
© PR Newswire
25.11.2024
ISIN: SE0022419784
Sectra AB
SECT_B
LISTED
STO
French hospital joins regional pathology solution from Sectra to enhance collaboration and speed up cancer diagnostics
Article
News Preview
LINKÖPING, Sweden, Nov. 25, 2024 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra's (STO: SECT B) digital pathology solution will be adopted by the hospital CH Béziers in France. They are the third hospital in the region to choose Sectra, providing them with a powerful platform for collaboration. The solution will...
Themefolio
Profiler
Peergroup
© EQS Newswire
22.11.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Comment on withdrawn non-binding offer
Article
News Preview
Ad hoc: Comment on withdrawn non-binding offer Hamburg, Germany – Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO) Evotec SE has taken notice of the statement made by Halozyme Therapeutics Inc. on 22 November, stating that it has withdrawn its non-binding proposal to acquire Ev......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.11.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Kommentar zum Rückzug eines unverbindlichen Angebots
Article
News Preview
Ad hoc: Kommentar zum Rückzug eines unverbindlichen Angebots Hamburg – Evotec SE (Frankfurter Wertpapierbörse: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO) Die Evotec SE hat die Erklärung der Halozyme Therapeutics Inc. vom 22. November 2024 zur Kenntnis genommen, wonach diese ihr unverbindliches Angebot zur Üb......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.11.2024
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Eckert & Ziegler erhöht erneut die Prognose für das laufende Geschäftsjahr
Article
News Preview
Eckert & Ziegler erhöht erneut die Prognose für das laufende Geschäftsjahr.Jahresprognose 2024: Umsatz von etwa 290 Mio. EUR (angehoben) EBIT vor Sondereinflüssen von rund 60 Mio. EUR (angehoben) Berlin, 22.11.2024 Die Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) erhöht erneut die Jahresprognose für das laufende Geschäftsjahr. Auf Basi......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.11.2024
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Eckert & Ziegler raises its forecast for the current financial year once again
Article
News Preview
Eckert & Ziegler raises its forecast for the current financial year once again.Forecast for 2024: Sales of around EUR 290 million (raised) EBIT before special items of around EUR 60 million (raised) Berlin, 22 November 2024 Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) is once again raising its annual forecast for the current financial ......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
22.11.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Comment on Withdrawn Non-Binding Offer
Article
News Preview
HAMBURG, GERMANY / ACCESSWIRE / November 22, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(SDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480)(NASDAQ:EVO)Evotec SE has taken notice of the statement made by Halozyme Therapeutics Inc. on 22 November, stating that it has withdrawn its non-binding proposal to acquire Evotec SE (NASDAQ:EVO...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.11.2024
ISIN: FI0009014377
Orion Oyj
ORNBV
LISTED
HEL
Orion Research Foundation grants EUR 1,109,000 for research in 2025
Article
News Preview
Orion Research Foundation grants EUR 1,109,000 for research in 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
21.11.2024
ISIN: US03168L1052
Amneal Pharmaceuticals Inc
AMRX
LISTED
NASDAQ
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist
Article
News Preview
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company, today announced the advancement of two key strategic initiatives. First, the Company has resubmitted to the U.S. Food and Drug Administration (FDA) its new drug application (NDA) for dihydroergotamine (DHE) prefilled syringe autoinjector for t...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.11.2024
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Grant of Restricted Stock Units and Warrants to Employees in Genmab
Article
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© BusinessWire
21.11.2024
ISIN: US98887Q1040
Zai Lab Limited
ZLAB
LISTED
NASDAQ
Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO® (Sulbactam-Durlobactam)
Article
News Preview
Zai Lab (“Zai Lab”, NASDAQ: ZLAB; HKEX: 9688) and Pfizer (“Pfizer”, NYSE: PFE) announced today a strategic collaboration for the novel antibacterial drug XACDURO® (sulbactam-durlobactam) in mainland China. Pfizer’s affiliated companies will be exclusively authorized to undertake and perform certain commercialization activities for XACDURO® in main...
Themefolio
Profiler
Peergroup
© PR Newswire
21.11.2024
ISIN: SE0022419784
Sectra AB
SECT_B
LISTED
STO
RSNA 2024 spotlight: Sectra showcases how radiologists can gain increased diagnostic throughput without working more hours
Article
News Preview
LINKÖPING, Sweden, Nov. 21, 2024 /PRNewswire/ -- At this year's Radiological Society of North America's annual meeting (RSNA), international medical imaging IT and cybersecurity company Sectra (STO: SECT B) will showcase its latest developments to make the radiologists' workflows faster. By providing all essential diagnostic tools in one applicat...
Themefolio
Profiler
Peergroup
© PR Newswire
21.11.2024
ISIN: SE0022419784
Sectra AB
SECT_B
LISTED
STO
RSNA 2024 spotlight: Sectra showcases how radiologists can gain increased diagnostic throughput without working more hours
Article
News Preview
LINKÖPING, Sweden, Nov. 21, 2024 /PRNewswire/ -- At this year's Radiological Society of North America's annual meeting (RSNA), international medical imaging IT and cybersecurity company Sectra (STO: SECT B) will showcase its latest developments to make the radiologists' workflows faster. By providing all essential diagnostic tools in one applicat...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.11.2024
ISIN: BE0003766806
Ion Beam Applications SA
IBAB
LISTED
EURONEXT
IBA Business Update – Third Quarter 2024
Article
News Preview
Louvain-la-Neuve, Belgium, 21 November 2024 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its business update for the third quarter ending 30 September 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
20.11.2024
ISIN: IE000LK2BOB4
Mural Oncology PLC
MURA
LISTED
NASDAQ
Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer
Article
News Preview
Nemvaleukin was generally well tolerated in ARTISTRY-1, a completed phase 1/2 clinical trial, with durable responses observed in both monotherapy and combination therapy across a range of heavily pretreated advanced solid tumors, including in platinum-resistant ovarian cancer (PROC), which does not typically respond to immunotherapies...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.11.2024
ISIN: DK0060336014
Novozymes A/S
NSIS B
LISTED
CPH
Trading by management and close relations of management
Article
News Preview
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
Themefolio
Profiler
Peergroup
© Globe Newswire
20.11.2024
ISIN: US75629V1044
Recursion Pharmaceuticals Inc
RXRX
LISTED
NASDAQ
Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery
Article
News Preview
SALT LAKE CITY, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The business combination of two AI-powered drug discovery and development companies, Recursion (Nasdaq: RXRX) and Exscientia has been completed, with Exscientia becoming a wholly owned subsidiary of Recursion creating a vertically-integrated and technology-enabled drug discovery platform. Exscient...
Themefolio
Profiler
Peergroup
© BusinessWire
19.11.2024
ISIN: US29332G1022
Enhabit Inc
EHAB
LISTED
NYSE
Enhabit Announces Participation in Upcoming BofA Home Care Conference
Article
News Preview
Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced its participation in the upcoming BofA Securities 2024 Home Care Conference. Enhabit’s President and Chief Executive Officer Barb Jacobsmeyer, incoming Chief Financial Officer Ryan Solomon, and Senior Vice President of Strategic Finance & Treasurer Jobie...
Themefolio
Profiler
Peergroup
© PR Newswire
19.11.2024
ISIN: GB00BN4HT335
Indivior PLC
INDV
LISTED
NASDAQ
Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024
Article
News Preview
Data show rapid initiation with once-monthly SUBLOCADE significantly improves retention in opioid use disorder (OUD) patients, especially among fentanyl-positive participants. Study also administered second SUBLOCADE injection a week later vs. standard 28 days, enabling patients to achieve and maintain target medication levels more quickly.Presen...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.11.2024
ISIN: FI0009014377
Orion Oyj
ORNBV
LISTED
HEL
Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies
Article
News Preview
ORION CORPORATION INVESTOR NEWS 19 NOVEMBER 2024 at 18.30 EET      ...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.11.2024
ISIN: SE0002190926
Karolinska Development AB
KDEV
LISTED
STO
Karolinska Development's portfolio company Modus Therapeutics secures bridge financing
Article
News Preview
STOCKHOLM, SWEDEN November 19, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Modus Therapeutics has secured access to bridge financing of up to SEK 5 million from Karolinska Development, the company’s largest shareholder. The funding enables Modus to initiate the recently approved phase 2a study...
Themefolio
Profiler
Peergroup
© BusinessWire
19.11.2024
ISIN: US8292141053
Simulations Plus Inc
SLP
LISTED
NASDAQ
Simulations Plus to Participate in the BTIG Digital Health Forum
Article
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications for the biopharma industry, today announced that Shawn O’Connor, chief executive officer, will participate in the virtual BTIG Digital Health Forum on Monday, November...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
Indices
DAX, DOW, S&P, FTSE...
Realtime Trading
With & without leverage
Currencies
EUR, USD, JPY, BRL, GBP ....
50 FX-Pairs
Top Conditions, Tied spreads, Mini/Micro
Commodities
Brent, WTI, Coffee, Wheat....
Long & Short
Crude oil, Agricultural & more
Metals
Gold, Silver, Palladium, Platinum
Hedging
Soft-,Heavy-, Precious Metals
Stocks & ETF
TSLA, NFLX, NVDA, MSFT, AAPL ....
Leveraged Equity Trading
USA, Europe, Asia
More information, click here

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2026 Select Sector SPDRs
* * *
More Sector related Investment Ideas
XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2026 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Wednesday, 21.01.2026, Calendar Week 04, 21st day of the year, 344 days remaining until EoY.